The aminoglycosides are used clinically in combination with ,3-lactam antibiotics. The combined use, however, produces an interaction and inactivation of the antibiotics. A study was designed to investigate the kinetics of the interaction in vitro. Four concentrations of aminoglycosides (5 to 20 ,ug of gentamicin and tobramycin per ml) and penicillins (100 to 600 pg of carbenicillin and ticarcillin per ml) were incubated in plasma (3 days, 3rC). Samples taken at 12-h intervals were analyzed for both aminoglycosides (radioimmunoassay) and penicillin (high-pressure liquid chromatography). In controls, degradation of all four antibiotics were by first-order reactions. In incubation mixtures of two antibiotics, the rate of loss of the aminoglycosides was greater than that in the controls, whereas the rate of loss of peniciHlins was not significantly increased. The loss of penicillins in incubation mixtures still appeared to be by first-order reactions. However, semilogarithmic plots of aminoglycoside concentrations were curvilinear, suggesting a second-order reaction. Aminoglycoside concentrations in incubation mixtures were fitted by computer to a model incorporating a second-order interaction between aminoglycosides and penicillins and the first-order loss of penicillin from the mixture. The interaction rate constant averaged 2.2 x 10-4 (,ug/ml h)-1 for interaction of both carbenicillin and ticarcillin with gentamicin and 1.6 x 10-(Ig/ml h)f1 for interaction of the penicillins with tobramycin. The effect of the interaction in vivo was examined by computer simulation using the kinetic parameters determined in vitro.
interaction in vivo was examined by computer simulation using the kinetic parameters determined in vitro.
The aminoglycoside antibiotics are often used in combination with P-lactam antibiotics to provide either a wider spectrum of activity against gram-negative bacilli or a synergistic antimicrobial effect against Pseudomonas aeruginosa and various enterobacteria. The combined use, however, can result in an interaction and loss of activity of both antibiotics. Since the early reports of inactivation of gentamicin by carbenicillin (6, 19, 26) , various aspects of the interaction have been investigated in vitro (4-12, 15, 16, 18, 21-29, 31, 32) and in vivo (2-5, 12, 14, 20, 25, 27, 30, 32, 33) . The mechanism of the interaction is thought to involve nucleophilic opening of the ,-lactam ring and reaction with an amino group of the aminoglycoside to form an inactive amide (32) . In vitro, the interaction is medium (21, 27, 32) , temperature (7, 8, 11, 21, 22, 26-28, 31, 32) , concentration (23, 24, 26, 27) , and time (24, 26, 32) dependent. The interaction is independent of pH within the pH range of 7.4 to 8.0 (10) . The extent of inactivation is also dependent on the aminoglycoside (7-10, 23-25, 27, 30) and P-lactam (4, 5, 8, 9, (21) (22) (23) 27) used. For example, gentamicin and tobramycin are inactivated to a greater extent than amikacin or netilmicin. Carbenicillin appears to cause greater inactivation than piperacillin. In vivo, the interaction is generally regarded as clinically significant only in patients with impaired renal function (3, 5, 27, 30, 33) .
This study was conducted to investigate the kinetics, i.e.,
to determine the order of the reaction and the interaction rate constants, of the aminoglycoside-p-lactam interaction.
Most previous studies have used too 
RESULTS
In control incubations of a single antibiotic in plasma at 37°C, carbenicillin and ticarcillin decayed rapidly. Approximately 50 to 60% of the original concentration remained after 24 h.Degradation of the penicillins appeared to be by a first-order reaction (Fig. 1) , with an average half-life of 39 h for carbenicillin and 26 h for ticarcillin over the concentration range of 100 to 600 ,ug/ml. Degradation was more rapid, and the rate constant was larger for ticarcillin than for carbenicillin (Table 1) . Compared with the penicillins, the aminoglycoside antibiotics were relatively stable when incubated alone in plasma (Fig. 1) . The loss at 24 h was less than 10%. Degradation half-lives were estimated as 30 to 50 days, but accuracy of the values was limited by the minor loss of drug over the 3-day period. Under the conditions used in the study there did not appear to be any major differences in degradation of tobramycin and gentamicin in control samples (Fig. 1) .
In antibiotic mixtures, the degradation of carbenicillin or ticarcillin remained a first-order reaction (Fig. 2) . Degradation rate constants were only slightly larger than in controls ( Table 1 ). The degradation of gentamicin and tobramycin, however, increased significantly when incubated with one of the penicillins (Fig. 2) . Loss of aminoglycoside at 24 h ranged from 20 to 80% (in contrast to less than 10% in controls) and was dependent on the concentration of penicillin (Fig. 3) . For example, at penicillin concentrations of 100 ,u.g/ml, more than 50% of the original gentamicin concentration remained at the end of the 3-day incubation period. A 50% loss occurred in 20 to 30 h with 200 ,ug of the penicillins per ml and in 6 to 10 h with 400 to 600 jig/ml. The initial aminoglycoside concentration had little effect on the degradation of the penicillins (Fig. 4) or the inactivation of the aminoglycoside itself (Table 2) .
Degradation curves of aminoglycosides in antibiotic mixtures were obviously nonlinear both on arithmetic and semilogarithmic graph paper (Fig. 2) b Calculated from reported Ki value and initial penicillin concentration, PO; ki = Ki (h-') P( (,ug/ml).
c Calculated from ki and initial penicillin concentration. PO; K, = ki (h-' pg`ml) Pi) (,ug/ml).
an average second-order interaction rate constant (ki) of 2.2 X 10-4 pg-1 h-1 ml for gentamicin and the penicillins and 1.6 X 10-4 pug-t h-1 ml for tobramycin. Although loss of the aminoglycosides was dependent on the concentration of carbenicillin or ticarcillin (Table 2) , ki was largely independent of the concentrations of both aminoglycosides and penicillins (Table 3) . Overall, the ki values for the interaction of gentamicin or tobramycin with carbenicillin were not significantly different (ANOVA, P > 0.05) from those with ticarcillin. However, the ki for gentamicin was larger than that of tobramycin. DISCUSSION
As previously reported by other investigators, loss of aminoglycosides over the 3-day incubation period was significantly greater in the presence of penicillin antibiotics. Results of early studies by Riff and Jackson (26, 27) have suggested that the rate of inactivation was influenced by the relative concentration of the two antibiotics. In the present study, with four different concentrations of all antibiotics, more than one combination generated the same ratio of penicillin to aminoglycoside concentrations; e.g. 100 ,ug of penicillin per ml with 5 ,ug of aminoglycoside per ml, 200 ,ug of penicillin per ml with 10 ,ug of aminoglycoside per ml, and 400 ,ug of penicillin per ml with 20 ,ug of aminoglycoside per ml, all yielded a concentration ratio of 20:1. The rate of inactivation for the same ratio of initial concentrations was higher with higher penicillin concentrations (Fig. 5) 24) showed similar results.
The rate of loss of aminoglycosides in antibiotic mixtures could not be described by a first-order reaction: graphs of the percent remaining with time were nonlinear even when plotted on semilogarithmic graph paper. This nonlinearity only becomes noticeable if concentrations are measured frequently. Although not discussed, there is evidence of such nonlinearity in earlier data presented in the literature (5, 12, 22) . O'Bey et al. (22) have fitted tobramycin concentrations determined over a 48-h period by log-linear regression. There are, however, systematic deviations of the data from the fitted line, indicating that the data should perhaps be fitted to some function other than monoexponential decay.
The decay curves in vitro could be described mathematically by a series of exponentials, e.g., Ae-' + Be-'. This approach, however, would not isolate or characterize an interaction constant which could be used to predict inactivation rates at different antibiotic concentrations or in different clinical situations. The chemistry of the interaction (30, 32) , its dependence on penicillin concentration, and the nonlinearity of the degradation profile suggest that the interaction could be described as a second-order reaction. A model combining first-order loss owing to the interaction also generated a biphasic decay curve and seemed to have wider applicability for clinical situations. This was the model used to fit data obtained in our in vitro experiments.
To fit aminoglycoside concentrations to such a model, penicillin concentrations must also be measured. Although investigators have consistently documented a correlation between the extent of the interaction and penicillin concentration, the observations have been based on the ihitial penicillin concentration. Few studies have measured both aminoglycoside and penicillin concentrations throughout the incubation period. Ervin et al. (5) did measure levels of PO values of 100 to 600 ,ug/ml, were in the same order of magnitude as Ki values reported previously (Table 4 ).
An initial illustration of the clinical implications of this study is provided by computer simulations of plasma concentrations after single, simultaneous intravenous doses of gentamicin and carbenicillin were administered to patients who had various degrees of renal dysfunction (Table 5) . These conditions would result in the maximum interaction of antibiotics. Simulations were based on a normal elimination half-life of 1 h for carbenicillin (17) The first-order elimination rate constant [kd(p) or kd(A)I replaces the first-order degradation rate constant (kp or kA) of the model, and ki remains to describe the second-order interaction. The effect of the interaction on penicillin concentrations is negligible. With normal renal function, the difference in gentamicin concentration at any time during an 8-h period would be less than 0.1 ,ug/ml for an initial carbenicillin concentration of 100 tg/ml. As renal function decreases, the decrease in concentration produced by the interaction becomes larger, increasing from ca. 0.2 pwg/ml for 20% kidney function to 0.8 ,g/ml with 5% kidney function. The larger the initial penicillin concentration the greater the difference becomes (note a difference of over 2 ,ug/ml at a carbenicillin concentration of 400 Rg/ml with a kidney function 5%). Such differences would accumulate on multiple dosing. Simulations of multiple dosing at various dosing intervals are now under way. 
